Curtis L. Ruegg

Curtis L. Ruegg

Chief Operating Officer at
NaNotics LLC
63 year
Health Technology
Consumer Services
Commercial Services

Profile

Curtis L.
Ruegg
is currently the Chief Operating & Development Officer at NaNotics LLC and a Member of The American Association of Immunologists.
He was also a Vice President-Development at InterMune, Inc., a Group Leader at Dendreon Corp., and an Executive Vice President-Technical Operations at Revance Therapeutics, Inc. Ruegg is an undergraduate of the University of California, Davis and holds a doctorate degree from The Johns Hopkins University School of Medicine.
He is also a Member of the American Association for the Advancement of Science.

Curtis L. Ruegg active positions

CompaniesPositionStart
Corporate Officer/Principal -
Chief Operating Officer 2022-04-20

Former positions of Curtis L. Ruegg

CompaniesPositionEnd
Chief Executive Officer 2019-11-30
REVANCE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2015-12-31
Chief Tech/Sci/R&D Officer 2005-12-31
INTERMUNE INC Corporate Officer/Principal 2003-12-31
DENDREON CORPORATION Corporate Officer/Principal -
See the detail of Curtis L. Ruegg's experience

Training of Curtis L. Ruegg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Commercial Services

Retail Trade

Consumer Services

Health Technology

Technology Services

  1. Stock Market
  2. Insiders
  3. Curtis L. Ruegg